Skip to main content
. 2019 Oct 23;40(2):101–113. doi: 10.3343/alm.2020.40.2.101

Table 1. The seven currently available classes of biological agents.

Biological Agent Action
Adalimumab, certolizumab pegol, etanercept, golimumab, infliximab Tumor necrosis factor inhibition
Anakinra Interleukin-1 receptor antagonism
Abatacept T cell costimulation inhibition (anti CD80/86)
Sarilumab, tocilizumab Interleukin-6 receptor antagonism
Ustekinumab The p40 subunit of interleukin-12/23 inhibition
Ixekizumab, secukinumab Interleukin-17 inhibition
Rituximab B-cell depletion (anti-CD20)